Revolutionizing Cardiac Care: UC San Diego Health Implants World’s First Dual Chamber and Leadless Pacemaker System

UC San Diego Health Becomes First in Region to Perform Dual-Chamber, Leadless Pacemaker Implantation

In February 2024, UC San Diego Health made history by implanting the world’s first dual chamber and leadless pacemaker system in a patient. This innovative system was approved by the U.S. Food and Drug Administration (FDA) in July 2023, and it is designed to help individuals with irregular heart rhythms, known as arrhythmias, that can lead to complications like palpitations, fainting, and stroke.

Atrial fibrillation is the most common type of arrhythmia, estimated to affect around 12.1 million people in the United States by 2030 according to the Centers for Disease Control and Prevention. Pacemakers and implantable cardioverter defibrillators (ICDs) are the standard treatments used to regulate irregular heartbeats.

The new leadless pacemaker system offers a more minimally invasive option for patients by being placed in both chambers of the heart and utilizing novel communication technology. This advancement in technology opens up new possibilities for treating individuals with heart arrhythmias. Dr. Ulrika Birgersdotter-Green, a cardiologist and the director of pacemaker and ICD services at UC San Diego Health, highlighted the importance of having the option to use a leadless pacemaker system on both sides of the heart to treat more individuals living with heart arrhythmias.

It is essential to note that nearly 80% of patients who receive a pacemaker require a dual chamber option. While leadless pacemakers have been preferred by patients, they were typically only available for individuals needing pacing on one side of the heart. This recent development represents a significant step forward in the treatment of arrhythmias and offers new hope for patients in need of such interventions.

Overall, this milestone achievement by UC San Diego Health marks an exciting advancement in medical technology that will benefit millions of people living with arrhythmias worldwide.

In February 2024, UC San Diego Health made history by implanting the world’s first dual chamber and leadless pacemaker system in a patient. This innovative system was approved by the U.S. Food and Drug Administration (FDA) in July 2023, and it is designed to help individuals with irregular heart rhythms, known as arrhythmias, that can…

Leave a Reply